Also trades as: PFE.DE (XETRA) · $vol 1M · PFE.NE (NEO) · $vol 1M · PFE.F (FSX) · $vol 0M · PFE.BA (BUE) · $vol 0M
PFE NYSE
Pfizer Inc.
1W: +0.8%
1M: -3.2%
3M: -2.6%
YTD: +4.8%
1Y: +14.2%
3Y: -18.3%
5Y: -19.0%
$25.90
-0.05 (-0.19%)
Weekly Expected Move ±2.4%
$24
$25
$25
$26
$27
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
1 bullish
2 neutral
1 bearish
Articles (24h)
4
Hourly Sentiment (24h)
0.41
Bullish
7 bullish
2 neutral
2 bearish
Articles (7d)
11
Daily Sentiment (7 Days)
Articles (100)
The Most Important Healthcare Stock You're Not Watching
Catalyst Watch: Fedspeak ramps up post-Powell, core PCE, and box office blitz
J&J & Pfizer Face Patent Risks: Which Stock Looks Better Positioned?
Is Trending Stock Pfizer Inc. (PFE) a Buy Now?
Pfizer Builds Oncology Growth Around Padcev and Pipeline Expansion
Pfizer Expands Pneumococcal Vaccine Push With New Programs
Relay Therapeutics Reports Early Success For Investigational Drug In Rare Vascular Disorders
Supreme Court Hands Major Blow To Big Pharma's Fight Against Biden-Era Medicare Drug Pricing Law
Cancer Stocks That Are Advancing the Future of Oncology Care
3 Deeply Undervalued Stocks You Can Buy for Less Than $100 Right Now
Up 231%, Is RTX Proving Why It Was a Mistake for Honeywell to Replace RTX in the Dow Jones Industrial Average?
Will Korlym Continue to Aid CORT's Growth in 2026 After a Strong Q1?
My Top 3 Healthcare Stocks for May 2026
Pfizer Just Locked In Its Next 5 Years of Growth -- Here's How
Trump 'Most Favored Nation' drug policy risks China R&D takeover
PFE Stock Declines Post Q1 Beat: Book Profits or Stay Invested?
The Zacks Analyst Blog Meta, Pfizer, Salesforce and Smith-Midland
Should Eli Lilly Investors Worry About Its Newest Rival -- From Within?
Top Analyst Reports for Meta, Pfizer & Salesforce
These Analysts Increase Their Forecasts On Arvinas After Q1 Results
3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally
Can Pfizer Achieve High Single-Digit Revenue CAGR From 2029?
3 Struggling Stocks That Could Make for Great Contrarian Buys
Rigel Pharmaceuticals Inks Breast Cancer Drug Deal With Arvinas, Pfizer
Prediction: Pfizer Will Beat the Market Over the Next 5 Years
Tremfya, Icotyde Lead J&J's Post-Stelara Immunology Strategy
Peptide Wellness Market Could Near $300 Billion as Consumer Demand Accelerates
Pfizer, Arvinas ink licensing deal with Rigel for breast cancer therapy
Is Pfizer a Buy, Sell, or Hold in 2026?
Pfizer's Net Income Drops in Q1. Is Its Dividend Still Safe?
Is This a Sign Pfizer's Aggressive Growth Strategy Is Paying Off?
Hantavirus Scare Sparks Vaccine Stock Rally: Moderna, Novavax Climb
Is Most-Watched Stock Pfizer Inc. (PFE) Worth Betting on Now?
Notable healthcare headlines for the week: UnitedHealth, Pfizer, and CVS Health in focus
Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?
Most healthcare companies report higher Y/Y EPS in strong earnings week
Earnings Scoreboard: 82% of firms post Y/Y earnings growth, 88% of S&P 500 reporting firms top EPS estimates
Trump says unaware of a plan to fire FDA commissioner
3 Healthcare Stocks Every Retiree Should Consider
Got $5,000 to Invest in a Volatile Market? Here's Exactly Where I'd Put It.
Trump to fire FDA commissioner Marty Makary: WSJ
Guardant Health CMO resigns
Will Eli Lilly Be the First $2 Trillion Healthcare Stock? 3 Catalysts That Could Get It There.
Forget Eli Lilly: These 2 Stocks Have More Upside
Darzalex, Erleada & New Drugs Keep J&J's Oncology Engine Charged in Q1
NVAX Q1 Earnings Beat, Stock Jumps 16% on Matrix-M Deal Momentum
Eli Lilly To Invest $4.5 Billion More In Indiana Manufacturing Sites
Pfizer's 6.5% Dividend Yield Looked Too Good to Be True -- but Management Just Silenced the Skeptics
History Suggests These 3 Stocks Are Due for a Major Rebound
Why Novavax Stock Is Trading Higher On Wednesday?
Trump's Drug Pricing Deals Could Lead To $529 Billion Savings For The Economy Over The Decade: Report
Stock Market News for May 6, 2026
S&P 500 Hits New High As Oil Prices Fall: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone
FDA halts publication of studies on COVID, shingles vaccines
Down as Much as 55% and Still Magnificent: 3 Dividend Stocks Worth Holding for a Lifetime
Pfizer (PFE) Q1 2026 Earnings Transcript
Pfizer expects $59.5B-$62.5B 2026 revenue, cites post-2028 high single-digit CAGR visibility after Vyndamax settlement
BioNTech eliminating more than 1800 jobs as COVID vaccine sales dwindle
Pfizer Beats on Q1 Earnings, New & Acquired Drugs Drive Sales Growth
Pfizer Says Vyndamax Drug Patent Settlement Reshapes Post-2028 Revenue View
Dow Jumps Over 300 Points; Tyson Foods Posts Upbeat Earnings
Markets Await New Home Sales Data
Pre-Markets Bounce Back from Monday's Selloff
Pfizer (PFE) Reports Q1 Earnings: What Key Metrics Have to Say
Pfizer (PFE) Q1 Earnings and Revenues Top Estimates
Pfizer in charts: Specialty Care, Oncology and Biosimilars drive Q1 growth, offsetting Primary Care decline
Earnings Scheduled For May 5, 2026
Earnings Snapshot: Pfizer beats Q1 estimates but misses guidance
Pfizer beats Q1 street views
Dow Dips 550 Points Amid Iran War Flareup: Investor Sentiment Declines, But Fear Index Remains In 'Greed' Zone
Pfizer, Pinterest And 3 Stocks To Watch Heading Into Tuesday
Pfizer, Arvinas Win FDA Nod For First-Of-Its-Kind Breast Cancer Therapy
Pfizer Q1 preview: Analysts bullish on robust pipeline; comments on obesity pipeline, guidance in focus
How To Earn $500 A Month From Pfizer Stock Ahead Of Q1 Earnings
Eli Lilly Just Announced Fantastic News for Shareholders
Pfizer Stock: Still Priced Like It's Dead Money
Quant snapshot: Lumentum, Fastly among top-rated names as SUI Group, Service Properties lag
Healthcare earnings impress with 86% beat rate, yet sector lags: Earnings Scorecard
Earnings Scoreboard: 82% of S&P 500 reporting firms top EPS estimates as 78% of firms post Y/Y earnings growth
Catalyst Watch: Jobs report, Disney drama, Citi event, and Mickey D's crafted beverage push
Pfizer, Arvinas breast cancer therapy approved by the FDA
FDA said to have named Katherine Szarama as acting CBER chief
Trump Taps Nicole Saphier As Surgeon General Pick, Withdraws Casey Means' Nomination
Pfizer Just Scored a Win That Wall Street Can't Ignore
Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q1 Earnings
BMY's Q1 Earnings Top Estimates, Breyanzi, Camzyos Drive Sales
Ahead of Pfizer (PFE) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Eli Lilly (LLY) Beats Q1 Earnings and Revenue Estimates
Bristol-Myers posts Q1 beat thanks to growth portfolio
Elizabeth Warren Calls Trump's '600%' Drug Price Claim Mathematically Impossible: 'His Promise Is As Empty As…'
Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead?
Pfizer Says Cancer Therapy Beats Standard Therapy In Late-Stage Blood Cancer Study
Pfizer posts late-stage trial win for multiple myeloma therapy Elrexfio
2 High-Yielding Dividend Stocks to Buy for Passive Income in April
Why Pfizer (PFE) Dipped More Than Broader Market Today
Pfizer Stock Is Declining Today: What's Happening?
Amneal 2026-2027 Upside From Biosimilars Scale
Should You Buy, Sell, or Hold Pfizer at $27?
Earnings Preview: Pfizer (PFE) Q1 Earnings Expected to Decline
BridgeBio gains after settlement in Pfizer Vyndamax patent dispute